Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib
The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organization
Prizes to be awarded to top global and regional submissions
Cyto-Mine Chroma is a multiplexing-capable, fully-automated single cell analysis platform that can encapsulate, analyze, sort, and dispense viable single cells
Nanoparticle Size and Zeta Potential Analyzer
Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques
The assay is designed to improve infection control in healthcare settings through the rapid identification of patients suspected of Candida auris colonization
Agilent has undertaken the highest sponsorship level of My Green Lab and is the first institution to sponsor the My Green Lab certification program
Dr. Ivan Cornella-Taracido, of Cedilla Therapeutics, discusses his work looking for therapeutic targets by harnessing protein homeostasis, and shares his insights into the future of drug discovery
Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA
Cobalt's portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value for pharmaceutical and biopharma customers
By offering shared access to instrumentation and experienced cryo-EM scientists, the center allows companies to evaluate and incorporate the technology into existing workflows without building the infrastructure in-house
BioPAT Viamass provides high-resolution real-time viable capacitance-based biomass measurement directly in the cell culture, enabling direct inline monitoring of cell growth and advanced, precise analysis
Leading global pharmaceutical company presented Pangaea Data’s Novel AI to automatically generate textual clinical narratives for regulatory reports
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship
Explore the key differences between the USA and the EU and UK as non-tariff barriers come under scrutiny
